NHS Generic Pharmaceuticals - Wave 16a
Estimated value
£260.0m
goods
Awarded value
—
Suppliers
0
Lots
1
0 awarded
Published
21 May 2025
This is a preliminary market engagement notice
Map the supplier landscape and document your shortlist before opening the tender. The market simulation produces a defensible audit record you can attach to your procurement file.
Description
Wave 16a DLN & DNW (Eastern and North London and North West), Oral Products and Housekeeping Products for remaining regions
Scope
- Reference
- ocds-h6vhtk-051c3a
- Total value
- £260,000,000 excluding VAT£312,000,000 including VATAbove the relevant threshold
- Commercial tool
- Standalone contract
- Contract dates
- 01 Feb 2027 to 31 Jan 2029Possible extension to 31 Jan 2031
Option or options to extend (at the authority’s discretion) for a period or periods up to a total of 8 months. Total maximum contract length of 48 months
- Main category
- goods
- CPV classifications
- 33600000
- Contract locations
- North East England, United KingdomNorth West England, United KingdomEast Midlands, United KingdomWest Midlands, United KingdomEast of England, United KingdomSouth East England, United KingdomSouth West England, United Kingdom
- Particular suitability
- Small and medium-sized enterprises (SME)
Award criteria
Criteria the buyer will use to evaluate bids.
| Name | Description | Type | Weighting |
|---|---|---|---|
| Price is not the only award criterion | Price is not the only award criterion and all criteria are stated only in the procurement documents. | price | — |